CompletedNot Applicable

Diagnostic Value of MRI for Allergic Broncho-Pulmonary Aspergilloses

France25 participantsStarted 2017-09-14

Plain-language summary

The aim of the study is to compare the concordance between chest computerized tomography-scan (CTscan) and Magnetic resonance Imaging (MRI) for the description of the abnormalities seen in Allergic BronchoPulmonary Aspergillosis (ABPA).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * study patients have a diagnosis of ABPA * control patients have severe asthma * All the patients are ≥ 18 years old, have social security care, signature of consent form Exclusion Criteria: * cystic fibrosis * other type of aspergilloses * contraindication for MRI * woman without effective contraception

What they're measuring

Concordance between chest CT scan and MRI for bronchial and pulmonary signs of ABPA (bronchiectases, infiltrates, impactions)

Timeframe: Day 0

Trial details

NCT IDNCT03265366

SponsorUniversity Hospital, Bordeaux

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-01-24

View on ClinicalTrials.gov More Allergic Bronchopulmonary Aspergilloses trials